@PsychedelicInstitute@mastodon.social avatar PsychedelicInstitute , to random

https://psychedelicmentalhealth.net/rapid-acting-nmda-and-gabaergic-modulators-in-mood-disorders-from-synaptic-mechanisms-to-clinical-practice-serretti-2025/ Spotlight: Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice (Serretti, 2025)
"Depression is increasingly conceptualized as a disorder of impaired synaptic plasticity and excitation-inhibition imbalance within corticolimbic circuits. Ketamine, brexanolone, zuranolone, offer complementary approaches to restore circuit function."

@georgetakei@universeodon.com avatar georgetakei , to random

Sounds like he should have been cutting back on his substance use, not our federal government.

A tweet by MeidasTouch (@MeidasTouch ) reads: "Oh." It includes a report stating that Elon Musk, while supporting Donald J. Trump with rallies and $275 million in donations last year, was heavily using drugs, including ketamine (affecting his bladder), Ecstasy, psychedelic mushrooms, and a daily medication box with about 20 pills, including Adderall, per sources and a photo of the box.
ALT
jbluespruce ,
@jbluespruce@mstdn.social avatar

@georgetakei Meanwhile, Trump is using “war on drugs” rhetoric to justify slapping on neighboring countries and sending to foreign .

@antiaall3s@chaos.social avatar antiaall3s , to random

· Researchers state that post-vaccine syndrome is characterized by persistent immune dysregulation & issues with blood coagulation.

· A drug called dapagliflozin, used to treat Type 2 Diabetes, is being investigated for in a clinical trial.

· A double-blind clinical trial is evaluating an experimental drug called REGN7544 for people with postural orthostatic tachycardia syndrome (POTS).

https://thesicktimes.org/2025/05/06/research-updates-may-6/

antiaall3s OP ,
@antiaall3s@chaos.social avatar

· A large, electronic health records study published in JAMA Internal Medicine estimated that over 100,000 Americans died each year between 2022 and 2024 from
· A new study published in Molecular & Cellular Proteomics found further evidence of abnormalities in post-exertional malaise
· A small phase two clinical trial is testing for fatigue and cognitive function

https://thesicktimes.org/2026/01/13/research-updates-january-13/